DAVITA INC
DVANYSETrading Snapshot
- Day Range
- $181.00 β $184.53
- 52-Week Range
- $101.00 β $247.49
- Volume (shares)
- 439,066
- Avg Volume (shares)
- β
- Shares Outstanding
- 63.8M
- Next Earnings
- 2026-10-29
Fundamentals Snapshot
- Annual Revenue
- $13.64B
- Last Q Revenue
- $3.55B
- P/E Ratio
- 13.8
- P/S Ratio
- 0.8x
- EPS (TTM)
- $12.21
- Dividend Yield
- β
- Dilution (1yr)
- +5.1%
DAVITA INC
DVAAbout DAVITA INC
DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of DaVita Inc. - DVA
NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. (βDaVitaβ or the βCompanyβ) (NYSE: DVA). Such investors are advised to contact Danielle Peyton atΒ ne

Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
DVA's Q3 2026 earnings are expected to rise on improving treatment volumes and cost discipline, but reimbursement pressures could weigh on profitability.

DaVita Brings Preventive Health Screenings Into Communities to Help Identify Hidden Health Risks
Nearly 1,000 people screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease risk DENVER, Oct. 27, 2026 /PRNewswire/ -- Millions of Americans are living with chronic disease and don'

DaVita HealthCare (DVA) Falls More Steeply Than Broader Market: What Investors Need to Know
DaVita HealthCare (DVA) closed at $183.64 in the latest trading session, marking a -1.32% move from the prior day.

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?
DaVita's 55.6% stock rally reflects stronger operating execution, improving treatment volumes and value-based kidney care gains despite reimbursement pressures.

DaVita Inc. $DVA Position Lifted by CWA Asset Management Group LLC
CWA Asset Management Group LLC grew its stake in DaVita Inc. (NYSE: DVA) by 15.9% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investo